Skip to main content
Caplight Logo









Adaptyv Bio

Adaptyv Bio

Private
LausanneHealthcare & Life Scienceshttps://www.adaptyvbio.com/

Last Round

Series A

Aug 26, 2026

Total Funding Raised

$50.85M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Adaptyv Bio is a biotechnology company that develops a next-generation protein engineering foundry integrating artificial intelligence, robotics, and nanofluidics to accelerate the design, synthesis, and testing of novel proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, ML Platforms

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Infrastructure

Keywords

laboratory-as-a-serviceLaaSprotein engineeringcloud laboratoryautomated wet labdrug discoveryhigh-throughput screeningAI-first biotechfoundry-as-a-serviceprotein synthesisbiotech infrastructurelab automationbiofoundryusage-based billingenzyme engineeringwet lab API

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Adaptyv Bio Comparables

Compare Adaptyv Bio with similar companies based on industry and business-model similarity.

Adaptyv Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ailurus Biotechnology
79%
Arctoris
78%
Tierra Biosciences
78%

Adaptyv Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 26, 2026
SeedSep 25, 2025
DebtJun 1, 2023
Pre SeedFeb 14, 2022
SeedAug 4, 2021
Grant
Apr 28, 2021

Key People

Founding team and executive leadership

Julian Englert

Co-Founder And CEO

Founding Team

Adaptyv Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 26, 2026

    $40M round led by Highland Europe.

  • Apr 18, 2026

    Added Cradle, a biotechnology/AI startup, as a customer.

Adaptyv Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Adaptyv Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Adaptyv Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range35
Year Founded2021
Last FundingAug 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?